Literature DB >> 21396915

Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint.

Mai Tsuchiya1, Naohiro Katagiri, Takao Kuroda, Hiroyuki Kishimoto, Kazuho Nishimura, Takuya Kumazawa, Naoya Iwasaki, Keiji Kimura, Junn Yanagisawa.   

Abstract

Cells eventually exit from mitosis during sustained arrest at the spindle checkpoint, without sister chromatid separation and cytokinesis. The resulting tetraploid cells are arrested in the subsequent G1 phase in a p53-dependent manner by the regulatory function of the postmitotic G1 checkpoint. Here we report how the nucleolus plays a critical role in activation of the postmitotic G1 checkpoint. During mitosis, the nucleolus is disrupted and many nucleolar proteins are translocated from the nucleolus into the cytoplasm. Among the nucleolar factors, Myb-binding protein 1a (MYBBP1A) induces the acetylation and accumulation of p53 by enhancing the interaction between p300 and p53 during prolonged mitosis. MYBBP1A-dependent p53 activation is essential for the postmitotic G1 checkpoint. Thus, our results demonstrate a novel nucleolar function that monitors the prolongation of mitosis and converts its signal into activation of the checkpoint machinery.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396915     DOI: 10.1016/j.bbrc.2011.03.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo.

Authors:  Ning Zhou; Kamini Singh; Maria C Mir; Yvonne Parker; Daniel Lindner; Robert Dreicer; Jeffrey A Ecsedy; Zhongfa Zhang; Bin T Teh; Alexandru Almasan; Donna E Hansel
Journal:  Clin Cancer Res       Date:  2013-02-12       Impact factor: 12.531

2.  Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells.

Authors:  Gustavo A Acuña Sanhueza; Leonie Faller; Babitha George; Jennifer Koffler; Vinko Misetic; Christa Flechtenmacher; Gerhard Dyckhoff; Peter P Plinkert; Peter Angel; Christian Simon; Jochen Hess
Journal:  BMC Cancer       Date:  2012-02-17       Impact factor: 4.430

3.  MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis.

Authors:  Kensuke Akaogi; Wakana Ono; Yuki Hayashi; Hiroyuki Kishimoto; Junn Yanagisawa
Journal:  BMC Cancer       Date:  2013-02-07       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.